Roth Capital Upgrades ANI Pharmaceuticals To Buy On Valuation

By: via Benzinga
On Monday, Roth Capital upgraded shares of ANI Pharmaceuticals Inc (NASDAQ: ANIP) from Neutral to Buy. After last ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.